Skip to main content

Effect of β-Blocker Therapy on the Frequency and Type of Cardiac Events in Patients with the Hereditary Long QT Syndrome

  • Conference paper
Cardiac Arrhythmias 1999
  • 142 Accesses

Abstract

The hereditary long QT syndrome (LQTS) is a genetic channelopathy in which affected individuals have prolonged ventricular repolarization, frequent syncopal episodes, and a propensity to sudden arrhythmic cardiac death [1, 2]. β-Blocker therapy is the recommended treatment of choice for this disorder, although other forms of therapy are also used including pacemakers to prevent bradycardia- induced ventricular tachyarrhythmias [3], surgical antiadrenergic therapy with left cervico-thoracic sympathetic ganglionectomy [4], and implantable car- dioverter defibrillators [5] in patients refractory to β-blocker therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Moss AJ, Schwartz PJ, Crampton RS, Locati E, Carleen E (1985) The long QT syndro-me: a prospective international study. Circulation 71:17–21

    Article  PubMed  CAS  Google Scholar 

  2. Moss AJ, Schwartz PJ, Crampton RS, Tzivoni D, Locati EH, MacCluer J, Hall WJ, Weitkamp L, Vincent M, Garson A Jr, Robinson JL, Benhorin J, Choi S (1991) The long QT syndrome: prospective longitudinal study of 328 families. Circulation 84:1136– 1144

    Article  PubMed  CAS  Google Scholar 

  3. Moss AJ, Liu JE, Gottlieb S, Locati E, Schwartz PJ, Robinson JL (1991) Efficacy of per-manent pacing in the management of high-risk patients with long QT syndrome. Circulation 84:1524–1529

    Article  PubMed  CAS  Google Scholar 

  4. Schwartz PJ, Locati E, Moss AJ, Crampton RS, Trazzi R, Ruberti U (1991) Left cardiac sympathetic denervation in the therapy of the congenital long QT syndrome: a worldwide report. Circulation 84:503–511

    Article  PubMed  CAS  Google Scholar 

  5. Priori SG, Zareba WJ, Napolitano C, Locati EH, Robinson JL, Diehl L, Schwartz PJ, Moss AJ (1996) The implantable cardioverter defibrillator (ICD) in the long QT syn-drome: data from the international registry. Pacing Clin Electrophysiol 19(2):556

    Google Scholar 

  6. Vincent GM, Fox J, Zhang L, Timothy KW (1996) Beta-blockers markedly reduce risk and syncope in KVLQT1 long QT patients. Circulation 94:I–204

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2000 Springer-Verlag Italia

About this paper

Cite this paper

Moss, A.J., Zareba, W., Hall, W.J., Robinson, J.L., Andrews, M.L. (2000). Effect of β-Blocker Therapy on the Frequency and Type of Cardiac Events in Patients with the Hereditary Long QT Syndrome. In: Raviele, A. (eds) Cardiac Arrhythmias 1999. Springer, Milano. https://doi.org/10.1007/978-88-470-2139-6_39

Download citation

  • DOI: https://doi.org/10.1007/978-88-470-2139-6_39

  • Publisher Name: Springer, Milano

  • Print ISBN: 978-88-470-2178-5

  • Online ISBN: 978-88-470-2139-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics